Previous 10 | Next 10 |
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...
SAN FRANCISCO, March 14, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ: CDMO) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/cdmo Contact An Attorney Now: CDMO@hbsslaw.com ...
SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Avid Bioservices, Inc. (NASDAQ: CDMO) investors who suffered substantial losses to submit your losses now . Visit: www.hbsslaw.com/investor-fraud/cdmo Contact An Attorney Now: CDMO@hbsslaw.com ...
Volcon Inc. (VLCN) is expected to report for Q4 2023 Tenaga Nasional Bhd ADR (TNABY) is expected to report for quarter end 2023-12-31 Hesai Group (HSAI) is expected to report for Q4 2023 Intrusion Inc. (INTZ) is expected to report $-0.14 for Q4 2023 Eliem Therapeutics Inc (ELYM) i...
2024-03-08 07:00:00 ET Summary Avid Bioservices' stock plummeted 30% post-earnings; Q3 revenue fell 11%, with significant drops in gross margin and operating income. Announced planned $160 million 7.00% Convertible Senior Notes; default on 2026 Notes triggers cross-default, compli...
NEW YORK, NY / ACCESSWIRE / March 7, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avid Bioservices, Inc. ("Avid Bioservices" or "the Company") (NASDAQ:CDMO). Investors who purchased Avid Bioservices securities are encouraged to obtain...
2024-03-07 12:49:07 ET More on Mid-day movers & stocks. Financial information for Nature Wood Group Financial information for Psyence Biomedical Ltd. Read the full article on Seeking Alpha For further details see: PBM and NWGL among mid-day movers
2024-03-07 10:01:04 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-07 08:35:57 ET More on Pre-market losers & stocks. Rail Vision shares rally as Main Line System gets EU approval and certifications Rail Vision wins contract valued at up to $5 million, shares jump Financial information for Airship AI Holdings, Inc. ...
2024-03-07 08:05:19 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices says revenues for third quarter of fiscal 2024 w...
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...